Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06867666 · ClinicalTrials.gov registry record · NA

Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury

A NA study of Insomnia and TBI (Traumatic Brain Injury), sponsored by Noctem.

Recruiting
Registry status
NA
Development phase
168
Enrollment target
1
Study location

NCT06867666: Recruiting NA study of Insomnia and TBI (Traumatic Brain Injury), sponsored by Noctem.

NCT06867666 is a NA study of Insomnia and TBI (Traumatic Brain Injury) that is actively recruiting participants, run by Noctem. The registered enrollment target is 168 participants, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06867666, a NA study of Insomnia and TBI (Traumatic Brain Injury), is actively recruiting participants, sponsored by Noctem.

RECRUITING
Registry status
NA
Development phase
168 participants
Enrollment target
1
Study location

Study Summary

The objective of the study is to conduct a randomized controlled trial of Cognitive Behavioral Therapy for Insomnia (CBT-I) in a sample of active-duty sailors with a history of traumatic brain injury (TBI). The investigators will test the impact of CBT-I on insomnia symptoms as well as post-concussive symptoms, psychological symptoms, and neurocognitive functioning in comparison to treatment as usual. The investigators will also compare the effectiveness of traditional in-person CBT-I and CBT-I delivered via a clinician-supervised digital health platform, Clinician Operated Assistive Sleep Technology (COAST) in comparison to treatment as usual on symptoms of insomnia, post-concussive symptoms, neurocognitive functioning, and psychological health. Participants will be assessed at baseline, post-treatment, and 3 months later.

Primary Outcome

The Insomnia Severity Index is a 7-item self-report questionnaire that assesses subjective severity of insomnia symptoms, degree of satisfaction with sleep, nature and noticeability of daytime impairments, and concerns caused by sleep difficulties. Each item is rated on a 0 to 4-point scale. A cut-off score of 14 has been shown to optimize sensitivity and specificity. Scores from 0 to 7 reflect clinically insignificant insomnia; scores from 8 to 14 reflects subthreshold insomnia; scores from 15

Interventions

  • BEHAVIORAL In Person CBT-I
  • BEHAVIORAL CBT-I via COAST

Study Locations (1)

California

  • Naval Medical Center San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2025-04-01
Est. Completion 2027-01-31
Phase NA
Noctem

2 total trials

What NCT06867666 shows while recruiting

NCT06867666 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which In Person CBT-I is the first listed.

NCT06867666 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06867666 about?

NCT06867666 is a clinical study titled "Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury". The objective of the study is to conduct a randomized controlled trial of Cognitive Behavioral Therapy for Insomnia (CBT-I) in a sample of active-duty sailors with a history of traumatic brain injury (TBI). The investigators will test the impact of CBT-I on insomnia symptoms as well as post-concussi...

What is the current status of trial NCT06867666?

This trial is currently recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2025-04-01. Estimated completion is 2027-01-31.

What conditions does trial NCT06867666 study?

This clinical trial studies the following conditions: Insomnia, TBI (Traumatic Brain Injury).

What interventions are being tested in trial NCT06867666?

The interventions under investigation include: In Person CBT-I (BEHAVIORAL), CBT-I via COAST (BEHAVIORAL).

Who is sponsoring clinical trial NCT06867666?

This trial is sponsored by Noctem, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06867666 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06867666's enrollment target sits among peer trials

168 42nd of 151 higher than 110 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06867666, the US trial registry maintained by the National Library of Medicine. NCT06867666 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.